Guggenheim Capital LLC Eli Lilly & CO Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Guggenheim Capital LLC holds 36,715 shares of LLY stock, worth $27.5 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

36,715

Previous 46,548 21.12%

Holding current value

$27.5 Million

Previous $42.1 Million 22.82%

% of portfolio

0.23%

Previous 0.3%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $7.59 Million - $9.44 Million	-9,833 Reduced 21.12%	36,715 $32.5 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $3.26 Million - $4.08 Million	-4,491 Reduced 8.8%	46,548 $42.1 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $9.01 Million - $12.1 Million	-15,217 Reduced 22.97%	51,039 $39.7 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $5.66 Million - $6.67 Million	-10,777 Reduced 13.99%	66,256 $38.6 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $8.76 Million - $12.1 Million	-20,163 Reduced 20.74%	77,033 $41.4 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $1.37 Million - $1.84 Million	3,915 Added 4.2%	97,196 $45.6 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $92,257 - $108,351	-297 Reduced 0.32%	93,281 $32 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $8.14 Million - $9.48 Million	-25,312 Reduced 21.29%	93,578 $34.2 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $2.58 Million - $2.94 Million	-8,714 Reduced 6.83%	118,890 $38.4 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $7.24 Million - $8.5 Million	-25,960 Reduced 16.91%	127,604 $41.4 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $1.95 Million - $2.42 Million	-8,293 Reduced 5.12%	153,564 $44 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.86 Million - $2.3 Million	8,252 Added 5.37%	161,857 $44.7 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $7.51 Million - $9.24 Million	33,882 Added 28.3%	153,605 $35.5 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $651,063 - $842,145	-3,606 Reduced 2.92%	119,723 $27.5 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $664,838 - $860,665	-4,046 Reduced 3.18%	123,329 $23 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $3.11 Million - $4.11 Million	23,814 Added 23.0%	127,375 $21.5 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $3.27 Million - $3.78 Million	-22,353 Reduced 17.75%	103,561 $15.3 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $3.08 Million - $3.71 Million	22,597 Added 21.87%	125,914 $20.7 Million
Q1 2020 Jun 02, 2020	SELL	$119.05 - $147.35 $9.78 Million - $12.1 Million	-82,154 Reduced 44.29%	103,317 $14.3 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $3.76 Million - $4.65 Million	35,150 Added 23.38%	185,471 $24.4 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $2.35 Million - $2.55 Million	21,965 Added 17.11%	150,321 $16.8 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1.02 Million - $1.19 Million	-9,198 Reduced 6.69%	128,356 $14.2 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $1.47 Million - $1.73 Million	-13,195 Reduced 8.75%	137,554 $17.9 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $2.38 Million - $2.67 Million	-22,489 Reduced 12.98%	150,749 $17.4 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $1.63 Million - $2.03 Million	18,953 Added 12.28%	173,238 $18.6 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $40.6 Million - $46.6 Million	-535,834 Reduced 77.64%	154,285 $13.2 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $874,193 - $1.03 Million	-11,780 Reduced 1.68%	690,119 $53.4 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $10.2 Million - $10.9 Million	124,217 Added 21.5%	701,899 $59.3 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $44.5 Million - $49.4 Million	577,682	577,682 $49.4 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Eli Lilly & CO Transaction History